MarketScreener Homepage > Equities > KOREA EXCHANGE (KOSDAQ) > Celltrion Pharm Inc A068760 KR7068760008

Report

No quotes available
--	KRW		--.--%

2020

S.Korea shares dip as surging global coronavirus cases dent sentiment

2020

South Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation

2020

S.Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation

Summary

News

Company

Financials

Financials

Sales 2018	147 B 133 M 133 M
Net income 2018	-9 389 M -8,53 M -8,53 M
Net Debt 2018	138 B 125 M 125 M
P/E ratio 2018	-230x
Yield 2018	-

Sales 2019	174 B 158 M 158 M
Net income 2019	8 602 M 7,81 M 7,81 M
Net Debt 2019	149 B 135 M 135 M
P/E ratio 2019	166x
Yield 2019	-

Capitalization	6 589 B 5 990 M 5 983 M
EV / Sales 2018	15,7x
EV / Sales 2019	9,06x
Nbr of Employees	328
Free-Float	42,5%

More Financials

Company

Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Companyâ€™s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and...

Sector

Pharmaceuticals

Calendar

More about the company

All news about CELLTRION PHARM INC

2020	S.Korea shares dip as surging global coronavirus cases dent sentiment	RE
2020	South Korea pharma Celltrion's COVID test gets U.S. emergency use authorisati..	RE
2020	S.Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation	RE
2020	S.Korea shares jump most in two weeks on falling virus cases, upbeat China da..	RE
2020	South Korea's Celltrion to merge with affiliates to set up holding company st..	RE

More news

News in other languages on CELLTRION PHARM INC

- No features available -

More news

Income Statement Evolution

More Financials

Managers and Directors

Name	Title
Jeong-Soo Suh	Chief Executive Officer & Director
Jung-Jin Seo	Chairman
Yu-Jin Jeon	Executive Board Member & Head-Finance
Haeng-Ok Kim	Non-Executive Director
Gyeong-Yeop Kim	Independent Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

CELLTRION PHARM INC		5 990



OTSUKA HOLDINGS CO., LTD.	1.04%	23 387
SUN PHARMACEUTICAL INDUSTRIES LTD.	0.40%	19 557
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.	-6.54%	18 317
ONO PHARMACEUTICAL CO., LTD.	-0.42%	14 968
ZHEJIANG NHU COMPANY LTD.	22.48%	13 642

More Results